http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102276598-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b4d53983adbf56dd0e7d0bf96f8ce5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-08 |
| filingDate | 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f71c22ca70627f50d25f98a3b82e63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314af53f9b56ebdd3260da47f71130f5 |
| publicationDate | 2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102276598-B |
| titleOfInvention | Benzothiazine-thione derivatives, preparation method thereof and purpose thereof |
| abstract | The invention belongs to the field of medicine, and especially relates to benzothiazine-thione derivatives, a preparation method thereof and use thereof. The invention intends to provide novel benzothiazine-thione derivatives with structures as a formula I. The benzothiazine-thione derivatives of the invention are novel compounds obtained on a basis of a large-scale selection. According to an experiment result, the benzothiazine-thione derivatives represented by the formula I have substantial effects in inhibiting mycobacterium tuberculosis. The effects of the derivatives are similar to or even better than that of isoniazid (MIC90=0.8muM). The derivatives have mycobacterium tuberculosis resisting activities. With the derivatives and the preparation methods, choices are provided for the development and application of antitubercular agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105294597-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105294597-A |
| priorityDate | 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.